Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
11/01/20241:54AMPR Newswire (US)OUC celebrates 100 years of excellence
11/01/20241:30AMPR Newswire (US)A. O. Smith Acquires PureitNYSE:AOSAO Smith Corp
11/01/20241:02AMPR Newswire (US)BB Living Opens 164-Home Single Family Rental Community in Florida's Epperson Ranch Community
11/01/20241:01AMPR Newswire (US)PharmaResearch Hosts 5th Global Symposium on 'Rejuran'
11/01/20241:00AMPR Newswire (US)Hitting Milestones, Coinstar and BBC Children in Need Celebrate Together with £1.6 Million in Donations
11/01/202412:50AMPR Newswire (Canada)Lancement officiel de l'expansion mondiale d'AutoReserve : Des possibilités infinies pour les réservations de restaurants avec un système hybride de technologie d'IA vocale et de réservations de sites Web
11/01/202412:01AMPR Newswire (US)Illinois Residents Can Now Get Free Lung Cancer Screenings
10/31/202411:01PMPR Newswire (Canada)Canadian Interest in American Whiskey Grows as DISCUS Launches New Fall Programming in Vancouver and Winnipeg
10/31/202411:00PMPR Newswire (US)Mother and Son Share Their Experience of Life-After-Death
10/31/202411:00PMPR Newswire (Canada)« À cause de mon âge », une campagne d'Estée Lauder Canada célébrant les réalisations et la beauté des femmes!
10/31/202411:00PMPR Newswire (Canada)"Because of My Age" An Estée Lauder Canada Campaign Celebrating Women's Achievements and Beauty!
10/31/202411:00PMPR Newswire (US)FireflySci Implements New Payment Policy to Ensure Business Stability Amid Economic Challenges
10/31/202411:00PMPR Newswire (US)MERGING NATURAL BEAUTY AND CULTURAL HERITAGE OF WEST NUSA TENGGARA, THE LUXURY COLLECTION DEBUTS THE SIRA, A LUXURY COLLECTION RESORT & SPA, LOMBOK
10/31/202411:00PMPR Newswire (US)Race Communications Brings 10G Fiber Internet to Four New Markets in Central California
10/31/202411:00PMPR Newswire (US)PCS Software Appoints Danielle Villegas as Chief Product Officer
10/31/202411:00PMPR Newswire (US)37th TIFFCOM Spotlight: Road Pictures Group's bold steps to redefine China's ACGN industry
10/31/202410:41PMPR Newswire (US)Fujitsu and AMD to begin strategic partnership to develop more sustainable computing infrastructure intended to accelerate open-source AI initiatives
10/31/202410:34PMPR Newswire (US)Xinhua Silk Road: Financial co-op for global common dev't under spotlight at forum held in E. China's Shanghai Jing'an
10/31/202410:34PMPR Newswire (US)Global Times: Dam benefits communities in Xinjiang, paving way for a secure ecological future for region
10/31/202410:34PMPR Newswire (US)/C O R R E C T I O N -- Akeso, Inc./
10/31/202410:26PMPR Newswire (US)Huawei's Yang Chaobin: 5.5G Unleashes the Potential of Mobile AI
10/31/202410:25PMPR Newswire (US)Global Times: Survey shows 90% of foreign firms feel satisfied or better about China's business environment
10/31/202410:25PMPR Newswire (Canada)Salon CIFF de Guangzhou 2025 : Dévoilement de nouveaux horizons pour l'industrie mondiale du meuble en mars 2025
10/31/202410:24PMPR Newswire (US)Fujitsu and AMD to begin strategic partnership to develop more sustainable computing infrastructure intended to accelerate open-source AI initiatives
10/31/202410:24PMPR Newswire (Canada)Fujitsu and AMD to begin strategic partnership to develop more sustainable computing infrastructure intended to accelerate open-source AI initiatives
10/31/202410:19PMPR Newswire (US)Advantech Unveils AFE-R360: A Next-Generation AMR Solution with MIPI-CSI & GMSL Camera Integration Powered by Intel® Core™ Ultra
10/31/202410:19PMPR Newswire (US)equipifi Selected as a Best Places to Work in the Valley for Second Consecutive Year
10/31/202410:18PMPR Newswire (US)Xinhua Silk Road: Financial co-op for global common dev't under spotlight at forum held in E. China's Shanghai Jing'an
10/31/20249:56PMPR Newswire (US)Global Times: Species thriving thanks to policy, consensus in China
10/31/20249:36PMPR Newswire (US)Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combination as First-Line Therapy for Biliary Tract Tumors, Compared to Durvalumab